N-[[5-[2,4-bis(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;N-[[5-(2,4-dichlorophenyl)-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;4-[1-methyl-3-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;4-[1-methyl-5-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;N-methyl-N-[[5-(4-piperidin-1-ylphenyl)-1H-pyrazol-4-yl]methyl]propan-1-amine
C81H102Cl2F6N18 — CID 159575750
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[5-[2,4-bis(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;N-[[5-(2,4-dichlorophenyl)-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;4-[1-methyl-3-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;4-[1-methyl-5-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;N-methyl-N-[[5-(4-piperidin-1-ylphenyl)-1H-pyrazol-4-yl]methyl]propan-1-amine
N-[[5-[2,4-bis(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;N-[[5-(2,4-dichlorophenyl)-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;4-[1-methyl-3-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;4-[1-methyl-5-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;N-methyl-N-[[5-(4-piperidin-1-ylphenyl)-1H-pyrazol-4-yl]methyl]propan-1-amine (PubChem CID 159575750) has the molecular formula C81H102Cl2F6N18 and a molecular weight of 1512.73 g/mol. Its IUPAC name is N-[[5-[2,4-bis(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;N-[[5-(2,4-dichlorophenyl)-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;4-[1-methyl-3-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;4-[1-methyl-5-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;N-methyl-N-[[5-(4-piperidin-1-ylphenyl)-1H-pyrazol-4-yl]methyl]propan-1-amine.
Molecular Properties
| Compound Name | N-[[5-[2,4-bis(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;N-[[5-(2,4-dichlorophenyl)-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;4-[1-methyl-3-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;4-[1-methyl-5-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;N-methyl-N-[[5-(4-piperidin-1-ylphenyl)-1H-pyrazol-4-yl]methyl]propan-1-amine |
|---|---|
| PubChem CID | 159575750 |
| Molecular Formula | C81H102Cl2F6N18 |
| Molecular Weight | 1512.73 g/mol |
| Exact Mass | 1510.78 |
| IUPAC Name | N-[[5-[2,4-bis(trifluoromethyl)phenyl]-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;N-[[5-(2,4-dichlorophenyl)-1H-pyrazol-4-yl]methyl]-N-methylpropan-1-amine;4-[1-methyl-3-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;4-[1-methyl-5-[[methyl(propyl)amino]methyl]pyrazol-4-yl]benzonitrile;N-methyl-N-[[5-(4-piperidin-1-ylphenyl)-1H-pyrazol-4-yl]methyl]propan-1-amine |
| SMILES | CCCN(C)Cc1c(-c2ccc(C#N)cc2)cnn1C.CCCN(C)Cc1cn[nH]c1-c1ccc(C(F)(F)F)cc1C(F)(F)F.CCCN(C)Cc1cn[nH]c1-c1ccc(Cl)cc1Cl.CCCN(C)Cc1cn[nH]c1-c1ccc(N2CCCCC2)cc1.CCCN(C)Cc1nn(C)cc1-c1ccc(C#N)cc1 |
| InChI | InChI=1S/C19H28N4.C16H17F6N3.2C16H20N4.C14H17Cl2N3/c1-3-11-22(2)15-17-14-20-21-19(17)16-7-9-18(10-8-16)23-12-5-4-6-13-23;1-3-6-25(2)9-10-8-23-24-14(10)12-5-4-11(15(17,18)19)7-13(12)16(20,21)22;1-4-9-19(2)12-16-15(11-20(3)18-16)14-7-5-13(10-17)6-8-14;1-4-9-19(2)12-16-15(11-18-20(16)3)14-7-5-13(10-17)6-8-14;1-3-6-19(2)9-10-8-17-18-14(10)12-5-4-11(15)7-13(12)16/h7-10,14H,3-6,11-13,15H2,1-2H3,(H,20,21);4-5,7-8H,3,6,9H2,1-2H3,(H,23,24);2*5-8,11H,4,9,12H2,1-3H3;4-5,7-8H,3,6,9H2,1-2H3,(H,17,18) |
| InChIKey | MIJOAIGETYXHGF-UHFFFAOYSA-N |
| XLogP | 18.69 |
| TPSA | 188.70 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 107 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1512.73 |
| LogP ≤ 5 | 18.69 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159575750 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.